Cargando…
The effectiveness of antiviral agents with broad-spectrum activity against chikungunya virus varies between host cell lines
Chikungunya virus (CHIKV) is a mosquito-borne virus that has recently emerged in the Western Hemisphere. Approved antiviral therapies or vaccines for the treatment or prevention of CHIKV infections are not available. This study aims to evaluate the antiviral activity of commercially available broad-...
Autores principales: | Franco, Evelyn J, Rodriquez, Jaime L, Pomeroy, Justin J, Hanrahan, Kaley C, Brown, Ashley N |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6202740/ https://www.ncbi.nlm.nih.gov/pubmed/30354193 http://dx.doi.org/10.1177/2040206618807580 |
Ejemplares similares
-
Combination Regimens of Favipiravir Plus Interferon Alpha Inhibit Chikungunya Virus Replication in Clinically Relevant Human Cell Lines
por: Franco, Evelyn J., et al.
Publicado: (2021) -
Broad-spectrum antiviral agents
por: Zhu, Jun-Da, et al.
Publicado: (2015) -
The broad spectrum host-directed agent ivermectin as an antiviral for SARS-CoV-2 ?
por: Jans, David A., et al.
Publicado: (2021) -
Defective viral genomes from chikungunya virus are broad-spectrum antivirals and prevent virus dissemination in mosquitoes
por: Levi, Laura I., et al.
Publicado: (2021) -
Novel activities of safe-in-human broad-spectrum antiviral agents
por: Ianevski, Aleksandr, et al.
Publicado: (2018)